Compare Kyowa Kirin Co., Ltd. with Similar Stocks
Dashboard
1
The company has declared Positive results for the last 3 consecutive quarters
- OPERATING CASH FLOW(Y) Highest at JPY 138,113 MM
- DIVIDEND PER SHARE(HY) Highest at JPY 3.4
- INTEREST COVERAGE RATIO(Q) The company hardly has any interest cost
2
With ROE of 8.17%, it has a very attractive valuation with a 1.41 Price to Book Value
3
Majority shareholders : FIIs
Stock DNA
Pharmaceuticals & Biotechnology
JPY 1,380,842 Million (Large Cap)
17.00
NA
0.04%
-0.28
8.17%
1.55
Revenue and Profits:
Net Sales:
145,162 Million
(Quarterly Results - Jun 2026)
Net Profit:
18,584 Million
Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
6.39%
0%
6.39%
6 Months
5.99%
0%
5.99%
1 Year
-5.23%
0%
-5.23%
2 Years
-13.74%
0%
-13.74%
3 Years
-4.32%
0%
-4.32%
4 Years
-18.51%
0%
-18.51%
5 Years
-26.4%
0%
-26.4%
Kyowa Kirin Co., Ltd. for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
9.65%
EBIT Growth (5y)
13.92%
EBIT to Interest (avg)
96.48
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
-0.26
Sales to Capital Employed (avg)
0.57
Tax Ratio
22.50%
Dividend Payout Ratio
48.41%
Pledged Shares
0
Institutional Holding
0.00%
ROCE (avg)
16.83%
ROE (avg)
7.78%
Valuation key factors
Factor
Value
P/E Ratio
17
Industry P/E
Price to Book Value
1.41
EV to EBIT
9.21
EV to EBITDA
7.36
EV to Capital Employed
1.57
EV to Sales
1.98
PEG Ratio
0.39
Dividend Yield
0.04%
ROCE (Latest)
17.10%
ROE (Latest)
8.17%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Bullish
Mildly Bullish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bullish
Mildly Bullish
Moving Averages
Bullish (Daily)
KST
Bullish
Bullish
Dow Theory
Mildly Bearish
Mildly Bullish
OBV
Mildly Bearish
Mildly Bullish
Shareholding Snapshot : Jun 2026
Shareholding Compare (%holding) 
Majority shareholders
Foreign Institutions
Domestic Funds
Held in 0 Schemes (0%)
Foreign Institutions
Held by 2 Foreign Institutions (0.0%)
Strategic Entities with highest holding
Highest Public shareholder
Quarterly Results Snapshot (Consolidated) - Jun'26 - YoY
Jun'26
Jun'25
Change(%)
Net Sales
145,162.00
125,929.00
15.27%
Operating Profit (PBDIT) excl Other Income
50,909.00
30,149.00
68.86%
Interest
0.00
2,539.00
-100.00%
Exceptional Items
0.00
0.00
Consolidate Net Profit
18,584.00
10,153.00
83.04%
Operating Profit Margin (Excl OI)
297.20%
190.00%
10.72%
USD in Million.
Net Sales
YoY Growth in quarter ended Jun 2026 is 15.27% vs -1.16% in Jun 2025
Consolidated Net Profit
YoY Growth in quarter ended Jun 2026 is 83.04% vs -56.13% in Jun 2025
Annual Results Snapshot (Consolidated) - Dec'25
Dec'25
Dec'24
Change(%)
Net Sales
496,826.00
495,558.00
0.26%
Operating Profit (PBDIT) excl Other Income
128,419.00
116,646.00
10.09%
Interest
1,539.00
709.00
117.07%
Exceptional Items
-14,627.00
-15,135.00
3.36%
Consolidate Net Profit
67,040.00
59,870.00
11.98%
Operating Profit Margin (Excl OI)
205.90%
185.40%
2.05%
USD in Million.
Net Sales
YoY Growth in year ended Dec 2025 is 0.26% vs 12.06% in Dec 2024
Consolidated Net Profit
YoY Growth in year ended Dec 2025 is 11.98% vs -26.26% in Dec 2024
About Kyowa Kirin Co., Ltd. 
Kyowa Kirin Co., Ltd.
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates 
No Company Details Available






